Gene · 23643
Papers4,579
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 4,579
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated analysis of single-cell and bulk RNA-sequencing reveals tumor heterogeneity and a signature based on NK cell marker genes for predicting prognosis in hepatocellular carcinoma. | Front Pharmacol | 2023 | 37397471 | PubTator, text mining | PubMed |
| Effect of curcumin on inflammatory biomarkers and iron profile in patients with premenstrual syndrome and dysmenorrhea: A randomized controlled trial. | Physiol Rep | 2023 | 37394650 | PubTator, text mining | PubMed |
| Therapeutic effects of Siegesbeckia orientalis L. and its active compound luteolin in rheumatoid arthritis: network pharmacology, molecular docking and experimental validation. | J Ethnopharmacol | 2023 | 37390879 | PubTator, text mining | PubMed |
| The immune role of the intestinal microbiome in knee osteoarthritis: a review of the possible mechanisms and therapies. | Front Immunol | 2023 | 37388748 | PubTator, text mining | PubMed |
PTPRC promoted CD8+ T cell mediated tumor immunity and drug sensitivity in breast cancer: based on pan-cancer analysis and artificial intelligence modeling of immunogenic cell death-based drug sensitivity stratification. | Front Immunol | 2023 | 37388747 | PubTator, text mining | PubMed |
| Serum TGF-β1 and CD14 Predicts Response to Anti-TNF-α Therapy in IBD. | J Immunol Res | 2023 | 37383609 | PubTator, text mining | PubMed |
| Editorial: Progress of programmed cell death in antitumor immunity. | Front Immunol | 2023 | 37377973 | PubTator, text mining | PubMed |
| Characterization of the Antimicrobial Activities of Trichoplusia ni Cecropin A as a High-Potency Therapeutic against Colistin-Resistant Escherichia coli. | Pharmaceutics | 2023 | 37376200 | PubTator, text mining | PubMed |
| Brain Endothelial Cells Play a Central Role in the Development of Enlarged Perivascular Spaces in the Metabolic Syndrome. | Medicina (Kaunas) | 2023 | 37374328 | PubTator, text mining | PubMed |
| Pivotal Clinical Study to Evaluate the Efficacy and Safety of Assistive Artificial Intelligence-Based Software for Cervical Cancer Diagnosis. | J Clin Med | 2023 | 37373717 | PubTator, text mining | PubMed |
| Prognostic Impact of Dihydropyrimidine Dehydrogenase Germline Variants in Unresectable Non-Small Cell Lung Cancer Patients Treated with Platin-Based Chemotherapy. | Int J Mol Sci | 2023 | 37372990 | PubTator, text mining | PubMed |
| Exosomes: A Promising Strategy for Repair, Regeneration and Treatment of Skin Disorders. | Cells | 2023 | 37371095 | PubTator, text mining | PubMed |
| High mobility group box 1 and a network of other biomolecules influence fatigue in patients with Crohn's disease. | Mol Med | 2023 | 37365509 | PubTator, text mining | PubMed |
| Saturated fatty acid-enriched small extracellular vesicles mediate a crosstalk inducing liver inflammation and hepatocyte insulin resistance. | JHEP Rep | 2023 | 37360906 | PubTator, text mining | PubMed |
| Extracorporeal Membrane Oxygenation Impact on Host Transcriptomic Response in Severe Coronavirus. | Ann Thorac Surg Short Rep | 2023 | 37360841 | PubTator, text mining | PubMed |
| Bacterial Membrane Vesicles: Physiological Roles, Infection Immunology, and Applications. | Adv Sci (Weinh) | 2023 | 37357142 | PubTator, text mining | PubMed |
| Editorial: Virus-induced innate immune response and inflammation. | Front Microbiol | 2023 | 37346746 | PubTator, text mining | PubMed |
| Pathogenic role of S100 proteins in psoriasis. | Front Immunol | 2023 | 37346040 | PubTator, text mining | PubMed |
| The Role of TLR4 in the Immunotherapy of Hepatocellular Carcinoma: Can We Teach an Old Dog New Tricks? | Cancers (Basel) | 2023 | 37345131 | PubTator, text mining | PubMed |
| Effects of gut microbiota on neurodegenerative diseases. | Front Aging Neurosci | 2023 | 37323141 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23643/papers?page=22